Use of personal protective equipment while admixing antineoplastic drugs during the COVID-19 pandemic era: Questionnaire survey in Niigata,Japan

Abstract

Get full access to this article

View all access options for this article.

References

Andrews SR and Dill JL. United States Pharmacopeia (USP) general chapter <800> hazardous drugs – handling in healthcare settings. Hospital Pharmacy 2017; 53(3): 132–133. DOI: 10.1177/0018578718763850.

Connor TH, Burroughs GE, McDiarmid, MA et al. National Institute for Occupational Safety and Health (N0IOSH) Alert: preventing occupational exposures to antineoplastic and other hazardous drugs in health care settings. Atlanta: DHHS (NIOSH) Publication, 2004, pp. 1–50.

Iacobucci

Covid-19: doctors still at “considerable risk” from lack of PPE, BMA warns. BMJ 2020; 368: m1316.

Kissler

Tedijanto

Goldstein

, et al. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period. Science 2020; eabb5793.

Office for Niigata Prefecture. Occurrence status of coronavirus disease, www.pref.niigata.lg.jp/sec/tokei/1356917412731.html (accessed 11 May 2020).